Search by Drug Name or NDC
NDC 14789-0013-10 Busulfan 60 mg/10mL Details
Busulfan 60 mg/10mL
Busulfan is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Nexus Pharmaceuticals LLC. The primary component is BUSULFAN.
MedlinePlus Drug Summary
Busulfan injection is used to treat a certain type of chronic myelogenous leukemia (CML; a type of cancer of the white blood cells) in combination with other medications to destroy bone marrow and cancer cells in preparation for a bone marrow transplant. Busulfan is in a class of medications called alkylating agents. It works by slowing or stopping the growth of cancer cells in your body.
Related Packages: 14789-0013-10Last Updated: 03/24/2024
MedLinePlus Full Drug Details: Busulfan Injection
Product Information
| NDC | 14789-0013 |
|---|---|
| Product ID | 14789-013_aab333f1-a02c-462a-bb87-d6270f8b46b9 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Busulfan |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Busulfan |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 60 |
| Active Ingredient Units | mg/10mL |
| Substance Name | BUSULFAN |
| Labeler Name | Nexus Pharmaceuticals LLC |
| Pharmaceutical Class | Alkylating Activity [MoA], Alkylating Drug [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA207794 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 14789-0013-10 (14789001310)
| NDC Package Code | 14789-013-10 |
|---|---|
| Billing NDC | 14789001310 |
| Package | 8 VIAL, SINGLE-DOSE in 1 CARTON (14789-013-10) / 10 mL in 1 VIAL, SINGLE-DOSE |
| Marketing Start Date | 2023-09-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |